Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD
详细信息 查看全文
- 作者：Anthony D. Ho1 ; &Dagger ; ; Johannes Schetelig2 ; &Dagger ; ; johannes.schetelig@uniklinikum-dresden.de" class="auth_mail" title="E-mail the corresponding author ; Tilmann Bochtler1 ; Markus Schaich2 ; Kerstin Schä ; fer-Eckart3 ; Mathias Hä ; nel4 ; Wolf Rö ; sler5 ; Hermann Einsele6 ; Martin Kaufmann7 ; Hubert Serve8 ; Wolfgang E. Berdel9 ; Matthias Stelljes9 ; Jiri Mayer10 ; Albrecht Reichle11 ; Claudia D. Baldus12 ; Norbert Schmitz13 ; Michael Kramer2 ; Christoph Rö ; llig2 ; Martin Bornhä ; user2 ; Christian Thiede2 ; &Dagger ; ; Gerhard Ehninger2 ; &Dagger ; ; on behalf of the Study Alliance Leukemia
- 关键词：Allogeneic transplantation ; Acute myeloid leukemia ; FLT3-ITD ; NPM1 mutation
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：22
- 期：3
- 页码：462-469
- 全文大小：493 K
文摘
- •
We analyzed the role of alloHCT in patients with AML depending on the ratio of mutant to wild-type FLT3 alleles.
- •
According to a predefined cutoff for the allelic ratio for mutant to wild-type FLT3-ITD, patients were grouped into high ratio (HR) and low ratio (LR) FLT3-ITD.
- •
AlloHCT improves EFS and OS in patients with HRFLT3-ITD but only EFS in LRFLT3-ITD AML.